Crescent Innovations, Inc. has developed a regenerative technology for joints (U.S. Patent 7,371,399). This platform technology has many applications, including treating TMJ Disorders.
Estimates are that as many as 30 million Americans suffer chronic pain associated with the Temporomandibular Joint (TMJ).
Crescent Innovations, Inc.’ goal is to develop long term non-surgical therapies for this disorder. Crescent Innovations, Inc. was awarded a Phase 1 Small Business Innovative Research (SBIR) Grant to develop this technology. A Phase 2 grant is pending.